GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity
Lindsey Wang, William Yang Wang, David C. Kaelber, Rong Xu, Nathan A. Berger
Abstract
This cohort study compares glucagon-like peptide 1 receptor agonists (GLP-1RAs) with 7 non–GLP-1RA antidiabetics among drug-naive patients with type 2 diabetes.
Topics & Concepts
MedicineType 2 diabetesGlucagon-like peptide 1 receptorOverweightObesityDiabetes mellitusInternal medicineColorectal cancerDrugGlucagon-like peptide-1OncologyCohortEndocrinologyReceptorCancerPharmacologyAgonistMetabolism, Diabetes, and CancerDiabetes Treatment and ManagementDiet and metabolism studies